These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6638998)

  • 21. Comparative in vitro activity of the new oral penem ALP-201 against aerobic and anaerobic bacteria.
    Rylander M; Nord CE; Norrby SR
    Eur J Clin Microbiol Infect Dis; 1989 Oct; 8(10):919-24. PubMed ID: 2512142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The sensitivity of anaerobic bacteria to chemotherapeutic agents (Zurich, 1991)].
    Wüst J; Hardegger U
    Schweiz Rundsch Med Prax; 1991 Dec; 80(52):1474-80. PubMed ID: 1815309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro evaluation of faropenem activity against anaerobic bacteria.
    Behra-Miellet J; Dubreuil L; Bryskier A
    J Chemother; 2005 Feb; 17(1):36-45. PubMed ID: 15828442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inoculum preparation for anaerobic susceptibility tests.
    Murray PR; Niles AC
    J Clin Microbiol; 1983 Sep; 18(3):733-4. PubMed ID: 6630450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial susceptibility of anaerobic bacteria in Australia.
    Chen SC; Gottlieb T; Palmer JM; Morris G; Gilbert GL
    J Antimicrob Chemother; 1992 Dec; 30(6):811-20. PubMed ID: 1289355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of antimicrobial susceptibilities of clinically isolated anaerobic bacteria by E-test, ATB-ANA and agar dilution.
    Koru O; Ozyurt M
    Anaerobe; 2008 Jun; 14(3):161-5. PubMed ID: 18424192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of telithromycin (HMR 3647) and seven other antimicrobial agents against anaerobic bacteria.
    Ackermann G; Schaumann R; Pless B; Claros MC; Rodloff AC
    J Antimicrob Chemother; 2000 Jul; 46(1):115-9. PubMed ID: 10882699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial susceptibility of anaerobic bacteria in New Zealand: 1999-2003.
    Roberts SA; Shore KP; Paviour SD; Holland D; Morris AJ
    J Antimicrob Chemother; 2006 May; 57(5):992-8. PubMed ID: 16507560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activities of trovafloxacin against 557 strains of anaerobic bacteria.
    Wexler HM; Molitoris E; Molitoris D; Finegold SM
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2232-5. PubMed ID: 8878617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymicrobial etiology of dental caries.
    Saini S; Mahajan A; Sharma JK; Arora ; Saini OP
    Indian J Pathol Microbiol; 1999 Jan; 42(1):25-9. PubMed ID: 10420681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial susceptibilities of anaerobic bacteria isolated at the Mayo Clinic during 1982 through 1987: comparison with results from 1977 through 1981.
    Musial CE; Rosenblatt JE
    Mayo Clin Proc; 1989 Apr; 64(4):392-9. PubMed ID: 2716353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Susceptibility of anaerobic bacteria to the new streptogramin RP 59500 in vitro.
    Nord CE; Lindmark A; Persson I
    Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1064-7. PubMed ID: 2559846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activity of a peptidyl prodrug, alafosfalin, against anaerobic bacteria.
    Grappel SF; Giovenella AJ; Nisbet LJ
    Antimicrob Agents Chemother; 1985 Jun; 27(6):961-3. PubMed ID: 4026269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotic susceptibility of blood culture isolates of anaerobic bacteria at a Norwegian university hospital.
    Kommedal O; Nystad TW; Bølstad B; Digranes A
    APMIS; 2007 Aug; 115(8):956-61. PubMed ID: 17696952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial susceptibility of clinical isolates of anaerobic bacteria in Ontario, 2010-2011.
    Marchand-Austin A; Rawte P; Toye B; Jamieson FB; Farrell DJ; Patel SN
    Anaerobe; 2014 Aug; 28():120-5. PubMed ID: 24923267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative activity of SCH 34343 against anaerobic bacteria.
    Sutter VL; Wexler H; Finegold SM
    Diagn Microbiol Infect Dis; 1986 Apr; 4(4):341-4. PubMed ID: 3698546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Susceptibility of anaerobic bacteria to Sch 34343 and other antibiotics.
    Glupczynski Y; Gordts B; van der Linden MP; Labbé M; Yourassowsky E; Butzler JP
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():193-8. PubMed ID: 4030548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative in-vitro activity of ceftazidime (GR-20263) and other beta-lactamase stable cephalosporins against anaerobic bacteria.
    Chow AW; Bartlett KH
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():91-5. PubMed ID: 19802974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative in vitro activity of PH-027 versus linezolid and other anti-anaerobic antimicrobials against clinical isolates of Clostridium difficile and other anaerobic bacteria.
    Phillips OA; Rotimi VO; Jamal WY; Shahin M; Verghese TL
    J Chemother; 2003 Apr; 15(2):113-7. PubMed ID: 12797385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative in-vitro activity of Sch 34343 and other antimicrobial agents against anaerobic bacteria.
    Nord CE; Olsson-Liljequist B
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():183-8. PubMed ID: 2863246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.